Skip to main content
An official website of the United States government

Early Detection Research Network (EDRN)

The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.

The DCP Cancer Biomarkers Research Group administers this program.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About EDRN

The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.

Visit the EDRN Website

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Langevin, Anne-Marie R.

University Of Texas Hlth Science Center
United States

Texas Pediatric NCORP 3UG1CA189855-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Langevin, Anne-Marie R.

University Of Texas Hlth Science Center
United States

Texas Pediatric NCORP 3UG1CA189855-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Leal, Ana Sofia Mendes

Indiana University Indianapolis
United States

Nrf2, immune cells and lung cancer 7R01CA226690-06 Marjorie Perloff, M.D.
Lee, Jeffrey Kuang Zou

Kaiser Foundation Research Institute
United States

Vanguard Study Administrative Supplement 3UG1CA287011-02S1 Elyse LeeVan, M.D., M.P.H.
Lee, Hakho

Massachusetts General Hospital
United States

Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array 5U01CA284982-03 Nicholas Hodges, Ph.D.
Lee, Juhun

University Of Pittsburgh At Pittsburgh
United States

Detecting Mammographically-Occult Cancer in Women with Dense Breasts Using Digital Breast Tomosynthesis 5R01CA269540-03 Sidney Fu, M.D.
Lee, Richard T

Beckman Research Institute/City Of Hope
United States

A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy 1R21CA260447-01A1 Rachel Altshuler, Ph.D.
Lee, Richard T

Beckman Research Institute/City Of Hope
United States

A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy 1R21CA260447-01A1 Rachel Altshuler, Ph.D.
Lehto, Rebecca H

Henry Ford Health + Michigan State University Health Sciences
United States

Support for bereaved friend and family caregivers of cancer patients 1R03CA282943-01A1 Brennan Streck, Ph.D., RN, M.P.H.
Lehto, Rebecca H

Henry Ford Health + Michigan State University Health Sciences
United States

Support for bereaved friend and family caregivers of cancer patients 1R03CA282943-01A1 Brennan Streck, Ph.D., RN, M.P.H.
Lehto, Rebecca H

Henry Ford Health + Michigan State University Health Sciences
United States

Support for bereaved friend and family caregivers of cancer patients 1R03CA282943-01A1 Brennan Streck, Ph.D., RN, M.P.H.
Lenburg, Marc Elliott

Boston University Medical Campus
United States

The Boston University - UCLA Lung Cancer Biomarker Characterization Center 5U2CCA271898-04 Guillermo Marquez, Ph.D.
Lesch, Bluma J

Yale University
United States

Defining signatures of epigenetic sensitization to lung cancer in a mouse model 5R21CA288677-02 Guillermo Marquez, Ph.D.
Leslie, Kimberly K.

University Of New Mexico Health Scis Ctr
United States

Advancing Hormone Therapy for Endometrial Cancer 1P01CA278735-01A1 Goli Samimi, Ph.D., M.P.H.
Lesser, Glenn J

Wake Forest University Health Sciences
United States

Wake Forest NCORP Research Base 3UG1CA189824-11S2 Brandy Heckman-Stoddard, Ph.D., M.P.H.